本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tetraphase Pharmaceuticals Inc.

2.20
0.0000
成交量:- -
成交额:- -
市值:1,597.91万
市盈率:-0.17
高:2.20
开:2.20
低:2.20
收:2.20
数据加载中...
2020/05/07

企业合并公告

Prospectuses and communications, business combinations
2020/04/30

企业合并公告

425 - Prospectuses and communications, business combinations
2020/04/28

重要事件披露

Current report, items 1.01, 2.03, and 9.01
2020/03/25

企业合并公告

Prospectuses and communications, business combinations
2020/03/20

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/17

企业合并公告

425 - Prospectuses and communications, business combinations
2020/03/16

企业合并公告

Prospectuses and communications, business combinations
2020/03/16

企业合并公告

Prospectuses and communications, business combinations
2020/03/16

重要事件披露

8-K - Current report
2020/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/31

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/31

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/23

超过5%披露

General statement of acquisition of beneficial ownership
2020/01/23

重要事件披露

Current report, items 1.01, 2.02, 3.02, 5.02, 8.01, and 9.01
2019/11/12

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/11/08

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/30

重要事件披露

Current report, items 1.01, 8.01, and 9.01